Over half of long COVID patients suffer persistent cognitive slowing, new study reveals

Study finds that 53% of long COVID patients experience significant cognitive slowing, a symptom that does not improve over time and is independent of the severity of the initial SARS-CoV-2 infection.

Pharma giant GSK is quitting BIO in latest setback for the lobbying group

Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies.

November 8, 2024

Flagship-founded Evelo Biosciences will dissolve after finding no ‘viable alternative’

Evelo Biosciences, a Flagship Pioneering biotech that set out to create new oral medicines dubbed monoclonal microbials, has decided to dissolve after multiple clinical failures

November 23, 2023

Moderna posts reported net loss of $3.6bn in Q3 earnings – Pharmaceutical Technology

Moderna has six Phase III programmes underway, including one for a CMV vaccine, which has completed enrolment. Credit: Tada Images via www.shutterstock.com. Moderna has posted

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.